{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","id":"ImmDS-2018-0002","parameter":[{"name":"assessentDate","valueDate":"2020-06-29"},{"name":"patient","resource":{"resourceType":"Patient","id":"2018-0002","name":[{"text":"Zoster: Dose #2 of the RZV (Shringrix) vaccine administered at two months after dose #1\nEvaluation_Test_Type: All Valid: Forecast Test\nGeneral_Description: This test case describes when a patient is administered dose #2 of the RZV vaccine at two months after dose #1, that the dose is considered to be valid."}],"gender":"male","birthDate":"1970-05-04"}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0002-dose1","status":"completed","date":"2020-05-04T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0002"},"wasNotGiven":false,"reported":false}},{"name":"immunization","resource":{"resourceType":"Immunization","id":"2018-0002-dose2","status":"completed","date":"2020-06-29T00:00:00.000","vaccineCode":{"coding":[{"system":"http://hl7.org/fhir/sid/cvx","code":"187","display":"zoster recombinant"}]},"patient":{"reference":"Patient/2018-0002"},"wasNotGiven":false,"reported":false}}]},"request":{"method":"PUT","url":"Parameters"}}]}